Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07434726

In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta

This study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inselspital University Hospital Bern

Bern, 3010, Switzerland

Location status: Recruiting

Location contact

Wolf E Hautz, MD

CONTACT

[email protected]

41316325701

About this study

Patients with in-hospital cardiac arrest (IHCA) outside the operating room, the coronary angiography suite and the intensive care unit (ICU) will be attended to by the hospitals resuscitation team and provided with advanced cardiac life support (ACLS) as per usual practice.

A research team will be deployed simultaneously and, when patients meet inclusion criteria, will randomize patients to ACLS alone or to ACLS plus balloon occlusion of the descending thoracic aorta by means of a resuscitative endovascular occlusion of the aorta (REBOA) catheter.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients suffering from in hospital cardiac arrest (IHCA), including patients with out of hospital cardiac arrest (OHCA) and return of spontaneous circulation (ROSC), transported to the emergency department, where they suffer a second arrest (IHCA)
  • successful placement of a femoral artery introducer sheath
  • any electrical cardiac activity seen in the initial rhythm analysis
  • ongoing effort of resuscitation as determined by study-independent resuscitation lead

Exclusion criteria

  • IHCA in the operating room, on intensive care unit or in the cardiac catheter laboratory
  • hospital visitors suffering from cardiac arrest
  • asystole seen in the initial rhythm analysis
  • (presumed) age under 18 years
  • known "do not resuscitate"-order
  • known or obvious pregnancy
  • traumatic cardiac arrest
  • known aortic pathologies that render cannulation impossible
  • known allergies to radiographic contrast agents

Treatment and study plan

resuscitative endovascular occlusion of the aorta (REBOA)

Device

Insertion of a balloon catheter through the common femoral artery, retrograde advancement of the catheter into the descending thoracic aorta, ballon occlusion of the aorta

Advanced Cardiac Life Support (ACLS)

Other

Advanced Cardiac Life Support (ACLS) as per American Heart Association (AHA) or European Resuscitation Council (ERC) standards

Primary outcomes

  1. Sustained ROSC

    Time frame: Up to 1 hour after study inclusion

    Any return of spontaneous circulation lasting longer then 20 minutes

Secondary outcomes

  1. Survival to hospital discharge

    Time frame: at hospital discharge, up to 90 days after study inclusion

    dead or alive

  2. Survival to six month

    Time frame: 6 month after study inclusion

    dead or alive

  3. neurologic outcome at the time of 30 days

    Time frame: Day 30 after study inclusion

    measured by means of modified ranking scale

  4. neurologic outcome at the time of six month

    Time frame: 6 month after study inclusion

    measured by means of modified ranking scale

  5. ICU-free days before hospital discharge

    Time frame: at hospital discharge, up to 90 days after study inclusion

  6. ICU-free days at 30 days

    Time frame: 30 days after study inclusion

Other outcomes

  1. non-invasive cerebral oxygenation during resuscitation

    Time frame: Continuously assessed during ongoing resuscitation, up to 1 hour after study inclusion

    Exploratory, measured in %

  2. cause of death

    Time frame: at six month

    exploratory, written description

  3. Troponin T trajectory

    Time frame: at inclusion, 30 minutes after inclusion and once up to day 3

    exploratory

  4. Neuron-Specific Enolase (NSE) trajectory

    Time frame: at inclusion, 30 minutes after inclusion and once up to day 3

    exploratory

Study contacts

Contact information is provided by the study sponsor or research team.

Cornelia Lammbrigger, RN

CONTACT

[email protected]

+41 31 632 57 01

Wolf E Hautz, MD, MME

CONTACT

[email protected]

+41 31 632 57 01

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Registry information

Official study title

CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta

Acronym: CPReboa

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Feb 27, 2026
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.